Congress
$1,001–$15,000
Traded May 15, 2025 · disclosed 25 days later
2 different filers disclosed DXCM within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 16, 2025
49 tracked managers disclosed the same change for Q1 2025. From a 13F filed May 16, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Increased
Compared with the manager's Q4 2024 13F
57,922
77,110
+33.1%
Share count drives classification; reported value also moves with price
0.41%
Within the filing's reported positions, not the manager's total assets
49
For Q1 2025
Congress
Traded May 15, 2025 · disclosed 25 days later
2 different filers disclosed DXCM within 90 days.
Michael Jon Brown (EVP, Chief Legal Officer) sold ~$843K of Dexcom
Planned saleSadie Stern (EVP, Chief HR Officer) sold ~$526K of Dexcom
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.